Reduced Number and Immune Dysfunction of CD4+ T Cells in Obesity Accelerate Colorectal Cancer Progression
Obesity, a known risk factor for various types of cancer, reduces the number and function of cytotoxic immune cells in the tumor immune microenvironment (TIME). However, the impact of obesity on CD4+ T cells remains unclear. Therefore, this study aimed to clarify the impact of obesity on CD4+ T cell...
Main Authors: | Kota Yamada, Masafumi Saito, Masayuki Ando, Tomoki Abe, Tomosuke Mukoyama, Kyosuke Agawa, Akihiro Watanabe, Shiki Takamura, Mitsugu Fujita, Naoki Urakawa, Hiroshi Hasegawa, Shingo Kanaji, Takeru Matsuda, Taro Oshikiri, Yoshihiro Kakeji, Kimihiro Yamashita |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/1/86 |
Similar Items
-
Assessment of risk factors for delayed gastric emptying after distal gastrectomy for gastric cancer
by: Tomosuke Mukoyama, et al.
Published: (2022-09-01) -
Impact of chronic kidney disease stage on morbidity after gastrectomy for gastric cancer
by: Satoshi Suzuki, et al.
Published: (2021-07-01) -
The modified Glasgow prognostic score is a reliable predictor of oncological outcomes in patients with rectal cancer undergoing neoadjuvant chemoradiotherapy
by: Atsushi Shimada, et al.
Published: (2023-10-01) -
Significance of Wnt/β-Catenin Signal Activation for Resistance to Neoadjuvant Chemoradiotherapy in Rectal Cancer
by: Shoji Miyako, et al.
Published: (2023-01-01) -
Protocol for a phase II study to evaluate the efficacy and safety of nivolumab as a postoperative adjuvant therapy for patients with esophageal cancer treated with preoperative docetaxel, cisplatin plus 5-fluorouracil treatment (PENTAGON trial).
by: Hironobu Goto, et al.
Published: (2024-01-01)